Novo Nordisk has a commercial relationship with Economist Impact, a division of The Economist Group. The Economist operates ...

CNBC's Karen Gilchrist discusses Wegovy-maker Novo Nordisk's efforts to regain U.S. market share amid increased competition ...

The Wilderness is the educational arm which will underpin the cultural shift needed to make the Forest of Dean sustainable in ...

You’ll pay more for a German car or Swiss cheese, but the EU enjoys zero tariffs on American goods. That’s a bad deal. | ...

Novo Nordisk hit by slowing Ozempic sales, Tesla shareholders sue Musk over Robotaxi - Stock market news and latest business ...

Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition ...

Russian invaders lost 187 personnel in Pokrovsk direction, and in total they attacked in that direction 33 times in 24 hours, ...

A 3D scan of the USS Albacore’s propeller at Albacore Park sparks new STEM outreach efforts and highlights advances in marine ...

US president Donald Trump said in an interview with CNBC last night that tariffs on semiconductors and pharma would be ...

For outsourcing and manufacturing professionals, 2024 may be remembered as the year capacity and partnerships took center ...

COPENHAGEN (Reuters) -Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug ...

Novo, valued at $650 billion in June last year, has shed over two-thirds of its value since. Its latest market cap is around ...